Loading insider details...
Beta
Latest Form 4 (Jun 12, 2026): Grant/Award of 50,500 AQST shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 50,500 | n/a |
| Jan 13, 2026 | LISATA THERAPEUTICS, INC. (LSTA) | Grant/Award | 30,456 | n/a |
| Jun 12, 2025 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 42,000 | $143.2K |
| Jan 13, 2025 | LISATA THERAPEUTICS, INC. (LSTA) | Grant/Award | 15,789 | n/a |
| Jun 21, 2024 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 38,000 | n/a |
| Jan 11, 2024 | LISATA THERAPEUTICS, INC. (LSTA) | Grant/Award | 19,480 | n/a |
| Jun 23, 2023 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 25,000 | n/a |
| Jan 11, 2023 | LISATA THERAPEUTICS, INC. (LSTA) | Grant/Award | 20,000 | n/a |
| Jun 24, 2022 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 25,000 | n/a |
| Jan 12, 2022 | CALADRIUS BIOSCIENCES, INC. (CLBS) | Grant/Award | 65,430 | n/a |